Dishman’s Bavla unit completes Japanese PMDA audit

07 Dec 2017 Evaluate

Dishman Carbogen Amcis’ manufacturing plant in Bavla, Gujarat, India has successfully passed the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) audit without any observations. This development is again a testimony to the strong focus the company lays on their quality systems and processes.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Dishman Carbogen Amc Share Price

208.80 -10.15 (-4.64%)
23-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×